Sectra ABMIL:1SECT 76 10-Year ROIIC % is 17.59 as of Apr. 2026. GuruFocus rates MIL:1SECT with a GF Score™ of 76/100 and a GF Value™ of €28.93 (Fairly Valued). Among 699 Medical Devices & Instruments companies, Sectra AB ranks better than 74.82% on this metric.
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Sectra AB's 10-Year ROIIC % for the quarter that ended in Apr. 2026 was 17.59%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Sectra AB's 10-Year ROIIC % or its related term are showing as below:
MIL:1SECT's 10-Year ROIIC % is ranked better than 74.82% of 699
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs MIL:1SECT: 17.59
Sectra AB (MIL:1SECT) 10-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sectra AB 10-Year ROIIC % Related Terms
Sectra AB 10-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Sectra AB's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1SECT vs ABT, SYK, MDT: 10-Year ROIIC % Comparison
For the Medical Devices subindustry, Sectra AB's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB 10-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Sectra AB's 10-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sectra AB (MIL:1SECT) has a 10-Year ROIIC % of 17.59 as of Apr. 2026. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Sectra AB and its competitors. According to the industry distribution chart, Sectra AB ranks #176 out of 699 companies in the Medical Devices & Instruments industry, placing it in the top 25.2%.
Is Sectra AB's 10-Year ROIIC % too high?
Sectra AB's current 10-Year ROIIC % is 17.59. The Medical Devices & Instruments industry median 10-Year ROIIC % is 2.31. Sectra AB's value of 17.59 is 661.5% above this industry median. Based on the distribution chart, Sectra AB ranks #176 out of 699 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sectra AB has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's 10-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #176 out of 699 companies for 10-Year ROIIC %. This puts Sectra AB in the upper half of its industry. The industry median 10-Year ROIIC % is 2.31. Sectra AB's value of 17.59 is 661.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year ROIIC % for a Medical Devices & Instruments company?
The median 10-Year ROIIC % among Medical Devices & Instruments companies is 2.31, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current 10-Year ROIIC % of 17.59 is 661.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year ROIIC % mean?
A high 10-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median 10-Year ROIIC % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current 10-Year ROIIC % is 17.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (MIL:1SECT) is currently considered Fairly Valued. The stock's GF Value™ is €28.93, compared to a current price of €27.38 — trading 5.4% below its estimated fair value. The current 10-Year ROIIC % is 17.59 and 661.5% above the Medical Devices & Instruments industry median of 2.31. Sectra AB's overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year ROIIC % calculated?
10-Year ROIIC % is calculated from a company's financial statements. For Sectra AB (MIL:1SECT), the current 10-Year ROIIC % is 17.59 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (MIL:1SECT) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of €27.38 is trading 5.4% below its estimated GF Value™ of €28.93.
GuruFocus considers Sectra AB to be Fairly Valued.
Key valuation signals for MIL:1SECT:
10-Year ROIIC %: 17.59
GF Value™: €28.93 vs. price of €27.38 (5.4% below fair value)
Industry Position: 661.5% above the Medical Devices & Instruments median (#176 of 699)
No single metric tells the full story. See the MIL:1SECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
76GF Score
Get the complete analysis for MIL:1SECT
10-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1SECT has been successfully added to your 
